| Atorvastatin-loaded nanostructured lipid carriers (NLCs): strategy to overcome oral delivery drawbacks M Elmowafy, HM Ibrahim, MA Ahmed, K Shalaby, A Salama, H Hefesha Drug delivery 24 (1), 932-941, 2017 | 124 | 2017 |
| Influence of the flexible liposomes on the skin deposition of a hydrophilic model drug, carboxyfluorescein: dependency on their composition M Badran, K Shalaby, A Al-Omrani The Scientific World Journal 2012, 2012 | 52 | 2012 |
| Multifunctional carbamazepine loaded nanostructured lipid carrier (NLC) formulation M Elmowafy, K Shalaby, MM Badran, HM Ali, MS Abdel-Bakky, ... International journal of pharmaceutics 550 (1-2), 359-371, 2018 | 51 | 2018 |
| Impact of nanostructured lipid carriers on dapsone delivery to the skin: in vitro and in vivo studies M Elmowafy, K Shalaby, HM Ali, NK Alruwaili, A Salama, MF Ibrahim, ... International Journal of Pharmaceutics 572, 118781, 2019 | 38 | 2019 |
| Improvement of ocular efficacy of levofloxacin by bioadhesive chitosan coated PLGA nanoparticles: box-behnken design, in-vitro characterization, antibacterial evaluation and … N Khan, NK Alruwaili, SNA Bukhari, B Alsuwayt, M Afzal, S Akhter, ... Iranian Journal of Pharmaceutical Research: IJPR 19 (1), 292, 2020 | 37 | 2020 |
| Polymeric nanoparticles for delivery of natural bioactive agents: recent advances and challenges M Elmowafy, K Shalaby, MH Elkomy, OA Alsaidan, HAM Gomaa, ... Polymers 15 (5), 1123, 2023 | 32 | 2023 |
| Surface-modified bilosomes nanogel bearing a natural plant alkaloid for safe management of rheumatoid arthritis inflammation MH Elkomy, NK Alruwaili, M Elmowafy, K Shalaby, A Zafar, N Ahmad, ... Pharmaceutics 14 (3), 563, 2022 | 32 | 2022 |
| Long-acting paliperidone parenteral formulations based on polycaprolactone nanoparticles; the influence of stabilizer and chitosan on in vitro release, protein adsorption, and … M Elmowafy, NK Alruwaili, K Shalaby, KS Alharbi, WM Altowayan, ... Pharmaceutics 12 (2), 160, 2020 | 28 | 2020 |
| Development and machine-learning optimization of mucoadhesive nanostructured lipid carriers loaded with fluconazole for treatment of oral candidiasis MH Elkomy, M Elmowafy, K Shalaby, AF Azmy, N Ahmad, A Zafar, HM Eid Drug Development and Industrial Pharmacy 47 (2), 246-258, 2021 | 27 | 2021 |
| Soy isoflavone-loaded alginate microspheres in thermosensitive gel base: attempts to improve wound-healing efficacy M Elmowafy, K Shalaby, A Salama, GM Soliman, NK Alruwaili, ... Journal of Pharmacy and Pharmacology 71 (5), 774-787, 2019 | 23 | 2019 |
| Polymeric nanoparticles based topical gel of poorly soluble drug: formulation, ex-vivo and in vivo evaluation M Elmowafy, A Samy, AE Abdelaziz, K Shalaby, A Salama, MA Raslan, ... Beni-Suef University journal of basic and applied sciences 6 (2), 184-191, 2017 | 21 | 2017 |
| Olive oil/pluronic oleogels for skin delivery of quercetin: In vitro characterization and ex vivo skin permeability M Elmowafy, A Musa, TS Alnusaire, K Shalaby, MMA Fouda, A Salama, ... Polymers 13 (11), 1808, 2021 | 19 | 2021 |
| Influence of stabilizer on the development of luteolin nanosuspension for cutaneous delivery: An in vitro and in vivo evaluation M Elmowafy, K Shalaby, MM Al-Sanea, OM Hendawy, A Salama, ... Pharmaceutics 13 (11), 1812, 2021 | 18 | 2021 |
| The anticancer and EGFR-TK/CDK-9 dual inhibitory potentials of new synthetic pyranopyrazole and pyrazolone derivatives: X-ray crystallography, in vitro, and in silico … A Musa, SK Ihmaid, DL Hughes, MA Said, HS Abulkhair, AH El-Ghorab, ... Journal of Biomolecular Structure and Dynamics 41 (21), 12411-12425, 2023 | 16 | 2023 |
| Bilosomes as a promising nanoplatform for oral delivery of an alkaloid nutraceutical: Improved pharmacokinetic profile and snowballed hypoglycemic effect in diabetic rats MH Elkomy, HM Eid, M Elmowafy, K Shalaby, A Zafar, MA Abdelgawad, ... Drug delivery 29 (1), 2694-2704, 2022 | 16 | 2022 |
| Fatty alcohol containing nanostructured lipid carrier (NLC) for progesterone oral delivery: In vitro and ex vivo studies M Elmowafy, K Shalaby, MM Badran, HM Ali, MS Abdel-Bakky, ... Journal of Drug Delivery Science and Technology 45, 230-239, 2018 | 16 | 2018 |
| Phenylpyrazolone-1, 2, 3-triazole hybrids as potent antiviral agents with promising SARS-CoV-2 main protease inhibition potential A Musa, HS Abulkhair, A Aljuhani, N Rezki, MA Abdelgawad, K Shalaby, ... Pharmaceuticals 16 (3), 463, 2023 | 12 | 2023 |
| Potential of natural bioactive compounds in management of diabetes: Review of preclinical and clinical evidence A Zafar, NK Alruwaili, DS Panda, SS Imam, KS Alharbi, M Afzal, ... Current Pharmacology Reports 7, 107-122, 2021 | 11 | 2021 |
| Hybrid polylactic acid/Eudragit L100 nanoparticles: A promising system for enhancement of bioavailability and pharmacodynamic efficacy of luteolin M Elmowafy, NA Alhakamy, K Shalaby, S Alshehri, HM Ali, ... Journal of Drug Delivery Science and Technology 65, 102727, 2021 | 10 | 2021 |
| Development and assessment of phospholipid-based luteolin-loaded lipid nanocapsules for skin delivery M Elmowafy, K Shalaby, MH Elkomy, OA Alsaidan, HAM Gomaa, ... International Journal of Pharmaceutics 629, 122375, 2022 | 9 | 2022 |
